Sale of medicines for children with hyperactivity reaches maximum values ​​in 2022 – Society

The sale of medicines with methylphenidate, recommended for the treatment of hyperactivity and attention deficit, reached, in 2022, the highest value since 2003, according to data from the National Medicines Authority (Infarmed), cited by the Newspaper.

Last year, 288,217 packages were sold, a value considerably higher than in previous years. Sales of these drugs reached a peak in 2015 (283,000), before dropping considerably in times of a pandemic (220,000 in 2020).

Another analysis by Infarmed, also cited by Jornal de Notícias, reveals that, in 2021, methylphenidate was the most prescribed drug for children aged between 10 and 14 years.

Source: Correio da Manhã by

*The article has been translated based on the content of Correio da Manhã by If there is any problem regarding the content, copyright, please leave a report below the article. We will try to process as quickly as possible to protect the rights of the author. Thank you very much!

*We just want readers to access information more quickly and easily with other multilingual content, instead of information only available in a certain language.

*We always respect the copyright of the content of the author and always include the original link of the source article.If the author disagrees, just leave the report below the article, the article will be edited or deleted at the request of the author. Thanks very much! Best regards!